葡萄膜黑色素瘤经玻璃体细针穿刺活检针道的组织病理学分析
前瞻性连续观察性病例系列纳入10例以眼球摘除为初始治疗的葡萄膜黑色素瘤患者,在直视下行25或27G细针穿刺活检后摘除眼球并做组织病理学分析。平均随访20.4个月(范围9.9-31.7),所有标本均满足基因组分析所需细胞量,眼球摘除标本的巩膜、睫状体扁平部或睫状冠内均未见肿瘤细胞,1例在活检象限的前部玻璃体内见少量肿瘤细胞,无眶内复发。
要点
- 10例葡萄膜黑色素瘤患者行细针穿刺活检后摘除眼球,所有活检标本均满足基因组分析所需细胞量。
- 眼球摘除标本的巩膜、睫状体扁平部与睫状冠内均未见肿瘤细胞。
- 1例在活检象限前部玻璃体内见少量肿瘤细胞,无眶内复发。
核心结论
- 未报告医源性肿瘤播散,细针穿刺活检是安全的操作,可获得高细胞量用于细胞学和基因组分析,眼球外播散风险极小。
研究设计与样本
- 前瞻性、连续、观察性病例系列,在德克萨斯州休斯敦Retina Consultants of Houston与Houston Methodist Hospital的临床/手术环境中开展。
- 纳入10例计划以眼球摘除作为葡萄膜黑色素瘤初始治疗的患者,处理包括细针穿刺活检、眼球摘除和组织病理学分析。
- 在直视下使用25G或27G针行细针穿刺活检,标本细胞块行苏木精-伊红染色及HMB45(红色显色剂)与Ki67(棕色3,3'-二氨基联苯胺显色剂)双重免疫染色。
- 主要结局为B超和组织病理学分析所确定的肿瘤位置与尺寸,肿瘤类型通过基因表达谱和美国癌症联合委员会分期分类。
主要发现
- 眼球摘除后平均随访20.4个月(范围9.9-31.7)。
- 所有活检标本均满足基因组分析所需细胞量。
- 眼球摘除标本的巩膜、睫状体扁平部或睫状冠内均未含肿瘤细胞。
- 1例在活检部位所在象限的前部玻璃体内见少量肿瘤细胞聚集。
- 无患者发生眶内复发;研究期间4例发生非眶部转移性葡萄膜黑色素瘤,其中3例死亡、1例带肝转移存活。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Perform the first in vivo examination of fine needle aspiration biopsy (FNAB) scleral tracts to determine the incidence of iatrogenic extension of tumor cells. DESIGN: A prospective, consecutive, observational case series. METHODS: This study was performed in a clinical/surgical setting at Retina Consultants of Houston and Houston Methodist Hospital, Houston, Texas, and included 10 patients who were scheduled for enucleation as primary treatment for uveal melanoma. Treatment included FNAB, enucleation, and histopathologic analysis. The primary outcomes were tumor location and dimension as identified by B-scans and histopathologic analysis. Tumor type was classified by gene expression profile and American Joint Committee on Cancer staging. Twenty-five- or 27-gauge needles were used for FNAB under direct visualization. Cell blocks of acquired specimens were examined using hematoxylin-eosin stain and double immunostain using HMB45 with red chromogen and Ki67 with brown 3,3'-diaminobenzidine chromogen. RESULTS: Mean follow-up after enucleation was 20.4 months (range 9.9-31.7). All biopsy specimens had adequate yields for genomic analysis. No enucleation specimen contained tumor cells within sclera, pars plana, or pars plicata. One specimen contained a small collection of tumor cells within the anterior vitreous in the quadrant of the biopsy site. No patient developed an orbital recurrence. Four patients developed nonorbital metastatic uveal melanoma during the study period. Three of them died, and 1 is alive with hepatic metastasis. CONCLUSIONS: No iatrogenic extension of tumor was reported. FNAB is a safe procedure that produces a high cellular yield for cytologic and genomic analyses with minimal risk of extraocular dissemination.
引用
- Kim RS, Chevez-Barrios P, Bretana ME, et al. Histopathologic Analysis of Transvitreal Fine Needle Aspiration Biopsy Needle Tracts for Uveal Melanoma. Am J Ophthalmol. 2016. PMID: 27818205. doi:10.1016/j.ajo.2016.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。